These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26147295)

  • 1. Frequency and time to onset of community-acquired respiratory tract infections in patients receiving esomeprazole: a retrospective analysis of patient-level data in placebo-controlled studies.
    Estborn L; Joelson S
    Aliment Pharmacol Ther; 2015 Sep; 42(5):607-13. PubMed ID: 26147295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials.
    Estborn L; Joelson S
    Drug Saf; 2008; 31(7):627-36. PubMed ID: 18558796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
    Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
    Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials.
    Sultan N; Nazareno J; Gregor J
    Can J Gastroenterol; 2008 Sep; 22(9):761-6. PubMed ID: 18818790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.
    Johnson DA; Le Moigne A; Li J; Pollack C; Nagy P
    Clin Drug Investig; 2016 Jul; 36(7):531-8. PubMed ID: 27074935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
    Lovell DJ; Dare JA; Francis-Sedlak M; Ball J; LaMoreaux BD; Von Scheven E; Reinhardt A; Jerath R; Alpan O; Gupta R; Goldsmith D; Zeft A; Naddaf H; Gottlieb B; Jung L; Holt RJ
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):41. PubMed ID: 29941047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitors and Infant Pneumonia/Other Lower Respiratory Tract Infections: National Nested Case-control Study.
    Blank ML; Parkin L; Zeng J; Barson D
    J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):335-340. PubMed ID: 29601438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid resolution of sleep disturbances related to frequent reflux: effect of esomeprazole 20 mg in two randomized, double-blind, controlled trials.
    Johnson DA; Le Moigne A; Hugo V; Nagy P
    Curr Med Res Opin; 2015 Feb; 31(2):243-50. PubMed ID: 25478944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esomeprazole treatment of frequent heartburn: two randomized, double-blind, placebo-controlled trials.
    Peura DA; Traxler B; Kocun C; Lind T
    Postgrad Med; 2014 Jul; 126(4):33-41. PubMed ID: 25141241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection.
    McNicholl AG; Linares PM; Nyssen OP; Calvet X; Gisbert JP
    Aliment Pharmacol Ther; 2012 Sep; 36(5):414-25. PubMed ID: 22803691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
    JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
    Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
    Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
    Moraes-Filho JP; Pedroso M; Quigley EM;
    Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.
    Kuipers EJ; Sung JJ; Barkun A; Mössner J; Jensen D; Stuart R; Lau JY; Ahlbom H; Lind T; Kilhamn J
    Adv Ther; 2011 Feb; 28(2):150-9. PubMed ID: 21181319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness.
    Ansaldi F; De Florentiis D; Parodi V; Rappazzo E; Coppelli M; Martini M; Alicino C; Durando P; Icardi G
    J Prev Med Hyg; 2012 Jun; 53(2):94-7. PubMed ID: 23240167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
    Giuliano C; Wilhelm SM; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age.
    Sandström M; Davidson G; Tolia V; Sullivan JE; Långström G; Lundborg P; Brown K
    Clin Ther; 2012 Aug; 34(8):1828-38. PubMed ID: 22832034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.
    Gulmez SE; Holm A; Frederiksen H; Jensen TG; Pedersen C; Hallas J
    Arch Intern Med; 2007 May; 167(9):950-5. PubMed ID: 17502537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.